Cover Image

PP 1.10 - 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir

Saved in:

Bibliographic Details
Main Authors:	J. Howard (Author), C. Levinger (Author), W. Wang (Author), H. Takata (Author), S. Nathanson (Author), R. Fromentin (Author), N. Chomont (Author), L. Trautmann (Author), A. Bosque (Author)
Format:	Book
Published:	Elsevier, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal
by: Alexander M.L. Hayes
Published: (2020)

OP 5.2 - 00070 Characterization of a dual PTPN1/PTPN2 inhibitor to target latent HIV reservoirs
by: A. Bosque, et al.
Published: (2022)

Suppression of the HIV-1 reservoir with a potent Tat inhibitor
by: S. Valente, et al.
Published: (2015)

Hormonal control of HIV-1 latency by estrogen imparts gender-specific restrictions on the latent reservoir
by: J. Karn, et al.
Published: (2019)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

PP 1.36 - 00182 Effect of HIV-1C Transmitted/Founder Viruses 5'LTRand tat Genetic Variation on Viral Reservoir Size and Latency Reversal Potential
by: Shreyal Maikoo, et al.
Published: (2022)

PP 5.4 - 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review
by: Quinten Debrabander, et al.
Published: (2023)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016)

PP 1.33 - 00167 Integrated single-cell multi-omic profiling of HIV latency reversal
by: A. Manickam, et al.
Published: (2022)

PP 2.4 - 00038 Age and biological sex but not sex hormones influence IL-15 biological activity
by: C. Stover, et al.
Published: (2022)

21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: Adam Ward, et al.
Published: (2017)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

The contribution of memory CD4+ T cell subset phenotype to latency reversal efficiency
by: D.A. Kulpa, et al.
Published: (2017)

PP 2.9 - 00125 Impact of latency reversal agents on estrogen receptor alpha gene and protein expression
by: C. Ceriani, et al.
Published: (2022)

OP 1.7 - 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir
by: M. Pardons, et al.
Published: (2022)

Understanding persistence of the latent reservoir
by: R.F. Siliciano
Published: (2017)

BCL-2 inhibitor sensitizes the latent HIV reservoir to elimination by CTLs
by: S.-H. Huang, et al.
Published: (2017)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

Approaches to discover latency-reversing agents
Published: (2015)

PP 1.3 - 00022 Signaling pathways that activate P-TEFb to reverse HIV latency in CD4+ T cells
by: U. Mbonye, et al.
Published: (2022)

PP 2.13 - 00160 Enhancing Tolerability and Efficacy of Latency Reversing Agents in "Kick and Kill" HIV Cure Approaches
by: J. Moran, et al.
Published: (2022)

PP 1.22 - 00120 Suppression of CD4+ T-cell-intrinsic immunity by HIV-1 latency-reversing HDACi
by: J. Kazmierski, et al.
Published: (2022)

OP 2.7 - 00057 The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells
by: D.C. Copertino, et al.
Published: (2022)

Phorbol esters isolated from Croton megalobotrys reverse HIV latency ex vivo
by: I. Tietjen, et al.
Published: (2019)

PP 1.11 - 00075 Selective nuclear retention of spliced and unspliced HIV-1 mRNAs following latency reversal
by: E. Honeycutt, et al.
Published: (2022)

Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents
by: D.A. Kulpa, et al.
Published: (2015)

Low viral reservoir treated individuals show unusual HIV latency distribution
by: C. Gálvez, et al.
Published: (2019)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent
by: A. Macedo, et al.
Published: (2015)

In vivo massive expansion of a T-cell clone carrying a defective HIV genome: implication for the measurement of the HIV reservoir
by: R. Fromentin, et al.
Published: (2017)

OA4-4 Latency reversing agents induce HIV-1 protein expression in latently infected cells for cytotoxic T-lymphocyte antiviral recognition and killing
by: A. Ruiz, et al.
Published: (2016)

Large in vivo expansion and subsequent partial contraction of a T cell clone carrying a defective HIV genome reflect the dynamics of the HIV reservoir during ART
by: R. Fromentin, et al.
Published: (2019)

Identification of a promising new class of latency reversing agents
by: A. Gramatica, et al.
Published: (2017)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

PP 4.5 - 00064 Differentiation Enhances Reactivation of Latent HIV-1 Reservoir in CD4+ T Cells in PLWH With > 4 Years of Viral Suppression
by: Y. Kuzmichev, et al.
Published: (2022)

HIV-1 in the latent reservoir is largely sensitive to circulating T cells
by: J. Warren, et al.
Published: (2019)

Co-culture of T-cells with dendritic cells facilitates HIV latency in proliferating CD4+ T-cells: implications for the establishment and reversal of latency
by: N. Kumar, et al.
Published: (2015)